APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peanut Allergy Therapeutics

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

Selected research

Industry Growth & Trends

Global Peanut Allergy Therapeutics Industry Growth and Trends Forecast to 2032

28 December 2025112 pages

Choose your research edition.

Industry ResearchPeanut Allergy Therapeutics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Peanut Allergy Therapeutics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Peanut Allergy Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peanut Allergy Therapeutics Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Peanut Allergy Therapeutics Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

According to APO Research, the global Peanut Allergy Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Peanut Allergy Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peanut Allergy Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peanut Allergy Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peanut Allergy Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Peanut Allergy Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peanut Allergy Therapeutics Market by Company

Mylan

Bayer

UCB Pharma

J & J

Perrigo

GSK

Kaleo

Amneal Pharma

ALK Abello

Aimmune Therapeutics

HUAPONT Pharm

Allergy Therapeutics

ASIT Biotech

Sanofi

DBV Technologies

HAL Allergy

Intrommune Therapeutics

Peanut Allergy Therapeutics Segment by Type

Epinephrine Injection

Antihistamines

Oral Immunotherapy

Other

Peanut Allergy Therapeutics Segment by Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Other

Peanut Allergy Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Peanut Allergy Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Peanut Allergy Therapeutics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Peanut Allergy Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Peanut Allergy Therapeutics Market Share by Region (2021-2026) Table 4. Global Peanut Allergy Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Peanut Allergy Therapeutics Market Share by Region (2027-2032) Table 6. Global Peanut Allergy Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Peanut Allergy Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Peanut Allergy Therapeutics Market Size Share by Type (2021-2026) Table 9. Global Peanut Allergy Therapeutics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Peanut Allergy Therapeutics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Peanut Allergy Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Peanut Allergy Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Peanut Allergy Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Peanut Allergy Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Peanut Allergy Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2021-2026) & (US$ Million) Table 23. Global Peanut Allergy Therapeutics Market Size Share by Distribution Channel (2021-2026) Table 24. Global Peanut Allergy Therapeutics Market Size Forecasted by Distribution Channel (2027-2032) & (US$ Million) Table 25. Global Peanut Allergy Therapeutics Market Size Share Forecasted by Distribution Channel (2027-2032) Table 26. North America Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 27. North America Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 28. Europe Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 29. Europe Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 30. Asia-Pacific Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 31. Asia-Pacific Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 32. Latin America Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 33. Latin America Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 34. Middle East and Africa Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 35. Middle East and Africa Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 36. Peanut Allergy Therapeutics Industry Trends Table 37. Peanut Allergy Therapeutics Industry Drivers Table 38. Peanut Allergy Therapeutics Industry Opportunities and Challenges Table 39. Peanut Allergy Therapeutics Industry Restraints Table 40. Global Peanut Allergy Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Peanut Allergy Therapeutics Revenue Market Share by Company (2021-2026) Table 42. Global Peanut Allergy Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Peanut Allergy Therapeutics Key Company Headquarters & Area Served Table 44. Global Peanut Allergy Therapeutics Company, Product Type & Application Table 45. Global Peanut Allergy Therapeutics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Peanut Allergy Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Mylan Peanut Allergy Therapeutics Product Portfolio Table 52. Mylan Recent Development Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Bayer Peanut Allergy Therapeutics Product Portfolio Table 57. Bayer Recent Development Table 58. UCB Pharma Company Information Table 59. UCB Pharma Business Overview Table 60. UCB Pharma Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. UCB Pharma Peanut Allergy Therapeutics Product Portfolio Table 62. UCB Pharma Recent Development Table 63. J & J Company Information Table 64. J & J Business Overview Table 65. J & J Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. J & J Peanut Allergy Therapeutics Product Portfolio Table 67. J & J Recent Development Table 68. Perrigo Company Information Table 69. Perrigo Business Overview Table 70. Perrigo Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Perrigo Peanut Allergy Therapeutics Product Portfolio Table 72. Perrigo Recent Development Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. GSK Peanut Allergy Therapeutics Product Portfolio Table 77. GSK Recent Development Table 78. Kaleo Company Information Table 79. Kaleo Business Overview Table 80. Kaleo Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Kaleo Peanut Allergy Therapeutics Product Portfolio Table 82. Kaleo Recent Development Table 83. Amneal Pharma Company Information Table 84. Amneal Pharma Business Overview Table 85. Amneal Pharma Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Amneal Pharma Peanut Allergy Therapeutics Product Portfolio Table 87. Amneal Pharma Recent Development Table 88. ALK Abello Company Information Table 89. ALK Abello Business Overview Table 90. ALK Abello Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ALK Abello Peanut Allergy Therapeutics Product Portfolio Table 92. ALK Abello Recent Development Table 93. Aimmune Therapeutics Company Information Table 94. Aimmune Therapeutics Business Overview Table 95. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio Table 97. Aimmune Therapeutics Recent Development Table 98. HUAPONT Pharm Company Information Table 99. HUAPONT Pharm Business Overview Table 100. HUAPONT Pharm Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio Table 102. HUAPONT Pharm Recent Development Table 103. Allergy Therapeutics Company Information Table 104. Allergy Therapeutics Business Overview Table 105. Allergy Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio Table 107. Allergy Therapeutics Recent Development Table 108. ASIT Biotech Company Information Table 109. ASIT Biotech Business Overview Table 110. ASIT Biotech Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. ASIT Biotech Peanut Allergy Therapeutics Product Portfolio Table 112. ASIT Biotech Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Sanofi Peanut Allergy Therapeutics Product Portfolio Table 117. Sanofi Recent Development Table 118. DBV Technologies Company Information Table 119. DBV Technologies Business Overview Table 120. DBV Technologies Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. DBV Technologies Peanut Allergy Therapeutics Product Portfolio Table 122. DBV Technologies Recent Development Table 123. HAL Allergy Company Information Table 124. HAL Allergy Business Overview Table 125. HAL Allergy Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. HAL Allergy Peanut Allergy Therapeutics Product Portfolio Table 127. HAL Allergy Recent Development Table 128. Intrommune Therapeutics Company Information Table 129. Intrommune Therapeutics Business Overview Table 130. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio Table 132. Intrommune Therapeutics Recent Development Table 133. North America Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Peanut Allergy Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Peanut Allergy Therapeutics Market Share by Country (2021-2026) Table 136. North America Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Peanut Allergy Therapeutics Market Share Forecast by Country (2027-2032) Table 138. Europe Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Peanut Allergy Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Peanut Allergy Therapeutics Market Share by Country (2021-2026) Table 141. Europe Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Peanut Allergy Therapeutics Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Peanut Allergy Therapeutics Market Share by Country (2021-2026) Table 146. Asia-Pacific Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Peanut Allergy Therapeutics Market Share Forecast by Country (2027-2032) Table 148. Latin America Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Peanut Allergy Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Peanut Allergy Therapeutics Market Share by Country (2021-2026) Table 151. Latin America Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Peanut Allergy Therapeutics Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2021-2026) Table 156. Middle East & Africa Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Peanut Allergy Therapeutics Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Peanut Allergy Therapeutics Product Image Figure 3. Global Peanut Allergy Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Peanut Allergy Therapeutics Market Size (2021-2032) & (US$ Million) Figure 5. Global Peanut Allergy Therapeutics Market Share by Region: 2025 VS 2032 Figure 6. Global Peanut Allergy Therapeutics Market Share by Region (2021-2032) Figure 7. North America Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Epinephrine Injection Image Figure 13. Global Epinephrine Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antihistamines Image Figure 15. Global Antihistamines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Oral Immunotherapy Image Figure 17. Global Oral Immunotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Peanut Allergy Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Peanut Allergy Therapeutics Market Share by Type 2025 VS 2032 Figure 22. North America Peanut Allergy Therapeutics Market Size Share by Type (2021-2032) Figure 23. Europe Peanut Allergy Therapeutics Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Peanut Allergy Therapeutics Market Size Share by Type (2021-2032) Figure 25. Latin America Peanut Allergy Therapeutics Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Peanut Allergy Therapeutics Market Size Share by Type (2021-2032) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Peanut Allergy Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Peanut Allergy Therapeutics Market Share by Application 2025 VS 2032 Figure 35. North America Peanut Allergy Therapeutics Market Size Share by Application (2021-2032) Figure 36. Europe Peanut Allergy Therapeutics Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Peanut Allergy Therapeutics Market Size Share by Application (2021-2032) Figure 38. Latin America Peanut Allergy Therapeutics Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Peanut Allergy Therapeutics Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Peanut Allergy Therapeutics Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Peanut Allergy Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Peanut Allergy Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Peanut Allergy Therapeutics Market Share by Country (2021-2032) Figure 45. Europe Peanut Allergy Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Peanut Allergy Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peanut Allergy Therapeutics Market Share by Country (2021-2032) Figure 48. Asia-Pacific Peanut Allergy Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Peanut Allergy Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Peanut Allergy Therapeutics Market Share by Country (2021-2032) Figure 51. Latin America Peanut Allergy Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Peanut Allergy Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peanut Allergy Therapeutics Market Share by Country (2021-2032) Figure 54. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Epinephrine Injection
  • Antihistamines
  • Oral Immunotherapy
  • Other
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
Companies covered
  • Mylan
  • Bayer
  • UCB Pharma
  • J & J
  • Perrigo
  • GSK
  • Kaleo
  • Amneal Pharma
  • ALK Abello
  • Aimmune Therapeutics
  • HUAPONT Pharm
  • Allergy Therapeutics
  • ASIT Biotech
  • Sanofi
  • DBV Technologies
  • HAL Allergy
  • Intrommune Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Peanut Allergy Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Peanut Allergy Therapeutics Market Size by Region (2021-2032)
  5. 1.4.1 Global Peanut Allergy Therapeutics Market Size by Region (2021-2026)
  6. 1.4.2 Global Peanut Allergy Therapeutics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Peanut Allergy Therapeutics Market Size (2021-2032)
  8. 1.5.1 North America Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Peanut Allergy Therapeutics Market Size Growth Rate (2021-2032)
2 Peanut Allergy Therapeutics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Epinephrine Injection
  3. 2.1.2 Antihistamines
  4. 2.1.3 Oral Immunotherapy
  5. 2.1.4 Other
  6. 2.2 Global Peanut Allergy Therapeutics Market Size by Type
  7. 2.2.1 Global Peanut Allergy Therapeutics Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Peanut Allergy Therapeutics Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Peanut Allergy Therapeutics Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Peanut Allergy Therapeutics Market Size by Regions
  11. 2.3.1 North America Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Peanut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
3 Peanut Allergy Therapeutics Market by Distribution Channel
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacy
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Peanut Allergy Therapeutics Market Size by Distribution Channel
  6. 3.2.1 Global Peanut Allergy Therapeutics Market Size Overview by Distribution Channel (2021-2032)
  7. 3.2.2 Global Peanut Allergy Therapeutics Historic Market Size Review by Distribution Channel (2021-2026)
  8. 3.2.3 Global Peanut Allergy Therapeutics Market Size Forecasted by Distribution Channel (2027-2032)
  9. 3.3 Global Peanut Allergy Therapeutics Market Size by Regions
  10. 3.3.1 North America Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026)
  11. 3.3.2 Europe Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026)
  12. 3.3.3 Asia-Pacific Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026)
  13. 3.3.4 South America Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026)
  14. 3.3.5 Middle East and Africa Peanut Allergy Therapeutics Market Size Breakdown by Distribution Channel (2021-2026)
4 Global Market Dynamics
  1. 4.1 Peanut Allergy Therapeutics Industry Trends
  2. 4.2 Peanut Allergy Therapeutics Industry Drivers
  3. 4.3 Peanut Allergy Therapeutics Industry Opportunities and Challenges
  4. 4.4 Peanut Allergy Therapeutics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Peanut Allergy Therapeutics Revenue (2021-2026)
  2. 5.2 Global Peanut Allergy Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Peanut Allergy Therapeutics Key Company Headquarters & Area Served
  4. 5.4 Global Peanut Allergy Therapeutics Company, Product Type & Application
  5. 5.5 Global Peanut Allergy Therapeutics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Peanut Allergy Therapeutics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Peanut Allergy Therapeutics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Peanut Allergy Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Mylan
  2. 6.1.1 Mylan Company Information
  3. 6.1.2 Mylan Business Overview
  4. 6.1.3 Mylan Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Mylan Peanut Allergy Therapeutics Product Portfolio
  6. 6.1.5 Mylan Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Peanut Allergy Therapeutics Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 UCB Pharma
  14. 6.3.1 UCB Pharma Company Information
  15. 6.3.2 UCB Pharma Business Overview
  16. 6.3.3 UCB Pharma Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
  18. 6.3.5 UCB Pharma Recent Developments
  19. 6.4 J & J
  20. 6.4.1 J & J Company Information
  21. 6.4.2 J & J Business Overview
  22. 6.4.3 J & J Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 J & J Peanut Allergy Therapeutics Product Portfolio
  24. 6.4.5 J & J Recent Developments
  25. 6.5 Perrigo
  26. 6.5.1 Perrigo Company Information
  27. 6.5.2 Perrigo Business Overview
  28. 6.5.3 Perrigo Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
  30. 6.5.5 Perrigo Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 GSK Peanut Allergy Therapeutics Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Kaleo
  38. 6.7.1 Kaleo Company Information
  39. 6.7.2 Kaleo Business Overview
  40. 6.7.3 Kaleo Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
  42. 6.7.5 Kaleo Recent Developments
  43. 6.8 Amneal Pharma
  44. 6.8.1 Amneal Pharma Company Information
  45. 6.8.2 Amneal Pharma Business Overview
  46. 6.8.3 Amneal Pharma Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
  48. 6.8.5 Amneal Pharma Recent Developments
  49. 6.9 ALK Abello
  50. 6.9.1 ALK Abello Company Information
  51. 6.9.2 ALK Abello Business Overview
  52. 6.9.3 ALK Abello Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
  54. 6.9.5 ALK Abello Recent Developments
  55. 6.10 Aimmune Therapeutics
  56. 6.10.1 Aimmune Therapeutics Company Information
  57. 6.10.2 Aimmune Therapeutics Business Overview
  58. 6.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
  60. 6.10.5 Aimmune Therapeutics Recent Developments
  61. 6.11 HUAPONT Pharm
  62. 6.11.1 HUAPONT Pharm Company Information
  63. 6.11.2 HUAPONT Pharm Business Overview
  64. 6.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
  66. 6.11.5 HUAPONT Pharm Recent Developments
  67. 6.12 Allergy Therapeutics
  68. 6.12.1 Allergy Therapeutics Company Information
  69. 6.12.2 Allergy Therapeutics Business Overview
  70. 6.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
  72. 6.12.5 Allergy Therapeutics Recent Developments
  73. 6.13 ASIT Biotech
  74. 6.13.1 ASIT Biotech Company Information
  75. 6.13.2 ASIT Biotech Business Overview
  76. 6.13.3 ASIT Biotech Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
  78. 6.13.5 ASIT Biotech Recent Developments
  79. 6.14 Sanofi
  80. 6.14.1 Sanofi Company Information
  81. 6.14.2 Sanofi Business Overview
  82. 6.14.3 Sanofi Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
  84. 6.14.5 Sanofi Recent Developments
  85. 6.15 DBV Technologies
  86. 6.15.1 DBV Technologies Company Information
  87. 6.15.2 DBV Technologies Business Overview
  88. 6.15.3 DBV Technologies Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
  90. 6.15.5 DBV Technologies Recent Developments
  91. 6.16 HAL Allergy
  92. 6.16.1 HAL Allergy Company Information
  93. 6.16.2 HAL Allergy Business Overview
  94. 6.16.3 HAL Allergy Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
  96. 6.16.5 HAL Allergy Recent Developments
  97. 6.17 Intrommune Therapeutics
  98. 6.17.1 Intrommune Therapeutics Company Information
  99. 6.17.2 Intrommune Therapeutics Business Overview
  100. 6.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
  102. 6.17.5 Intrommune Therapeutics Recent Developments
7 North America
  1. 7.1 North America Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Peanut Allergy Therapeutics Market Size by Country (2021-2026)
  3. 7.3 North America Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Peanut Allergy Therapeutics Market Size by Country (2021-2026)
  3. 8.3 Europe Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Peanut Allergy Therapeutics Market Size by Country (2021-2026)
  3. 10.3 South America Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Peanut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst